Space, Missions, Technology, Medicine Corey Hubbard Space, Missions, Technology, Medicine Corey Hubbard

The Pharmacological Imperative: Solving Drug Challenges for Lunar & Martian Expeditions

Explore the frontiers of space pharmacology, analyzing profound knowledge gaps in drug pharmacokinetics and pharmacodynamics under extreme microgravity and radiation conditions. This research highlights the imperative for personalized medicine, innovative sampling methods (DUS/DBS), and enhanced pharmaceutical stability to safeguard astronaut health and optimize long-duration deep space missions to the Moon and Mars.

Read More
Technology, Wellness, Community, Values Corey Hubbard Technology, Wellness, Community, Values Corey Hubbard

Our Journey to Health Equity: Paving the Way for Fairer Care Through Data and Culture Change

Embark on Intermountain Healthcare's inspiring journey towards health equity! Discover how they're uniting the power of data with a commitment to culture change to create a fairer healthcare experience for all. From using clever dashboards to uncover disparities to fostering brave conversations about systemic racism, see how Intermountain is taking essential first steps, learning along the way, to build a future where everyone can live their healthiest life. It's a testament to progress, one thoughtful step at a time!

Read More
Medical Researchers, FDA Corey Hubbard Medical Researchers, FDA Corey Hubbard

Dialectical Thinking: A Drain on Your Well-being? Culture & Age Play a Role!

This study investigates the complex relationship between holding dialectical views on contradictions and psychological well-being, specifically examining depressive symptoms and life satisfaction. It explores the moderating roles of culture (European American vs. Asian American) and age, and the mediating role of mindfulness facets. Findings indicate that dialectical views are associated with increased depressive symptoms and lower life satisfaction primarily among younger European Americans,

Read More
Manipulation, Online, Technology Corey Hubbard Manipulation, Online, Technology Corey Hubbard

Did AI Manipulate You? Inside Switzerland's Controversial Reddit Experiment

Did AI truly manipulate Reddit users without their knowledge? Dive into the explosive details of the "exceptionally challenging" fake news study by Swiss-based researchers, linked to the University of Zurich, that secretly deployed AI bots using Large Language Models (LLMs) to invent opinions and influence public discourse on r/changemyview. Unaware participants debated AI-composed viewpoints, stretching ethical boundaries "beyond breaking point". This controversial experiment, which failed to inform participants in advance, "provoked a storm of criticism" from the Reddit community, researchers, and international media. Discover why researchers "disobeyed the rules" of the platform and their subsequent "full and deeply felt apology," even as questions of "bad science is bad ethics" and potential data protection violations persist.

Read More
Technology, Clinical Trials, Therapuetics Corey Hubbard Technology, Clinical Trials, Therapuetics Corey Hubbard

AI in Pharma & Healthcare: Unlocking Insights, Transforming Research & Clinical Trials

Discover the extensive applications of Artificial Intelligence (AI) in pharmaceutical and healthcare research. Learn how AI is used for drug discovery, disease diagnosis, including cancer and dementia, and personalized treatment. Explore AI's crucial role in clinical trials, aiding in design, patient selection, monitoring, and analysis, and its potential to uncover valuable insights hidden in clinical protocols. Find out how AI assists in forecasting epidemics and pandemics.


Read More
Medical Researchers, AI, Innovation Corey Hubbard Medical Researchers, AI, Innovation Corey Hubbard

Global Crises Impact Clinical Trials: Navigating Turbulence with Proactivity & IRT

Learn how global crises, from Brexit and COVID-19 to cybersecurity threats and natural disasters, are challenging clinical trial teams. Discover how proactivity, flexibility, collaboration, and IRT technology are key to minimizing participant disruption and ensuring study continuity in turbulent times.

Read More
Healthcare, Clinical Trials, Health Equity Corey Hubbard Healthcare, Clinical Trials, Health Equity Corey Hubbard

Why Healthcare Systems Need Redesign

Explore the significant impact of medical errors in healthcare, estimated to cause tens of thousands of deaths annually in the U.S.. Understand how systemic issues and processes contribute to preventable harm. Learn why system redesign, informed by human factors and systems engineering, is crucial for avoiding injuries to patients and improving safety.

Read More

Advancing Drug Development: Overcoming Clinical Trial Inefficiency

Learn how novel approaches to clinical trial design, including integrated models and adaptive methods, are addressing the high costs and inefficiency of traditional drug development, particularly in Phase II and III trials, to reduce attrition rates and increase productivity.

Read More
Health Equity, Alzheimers, BioMarkers Corey Hubbard Health Equity, Alzheimers, BioMarkers Corey Hubbard

Detecting Preclinical AD: Robust Longitudinal Cognitive Norms for LATINX

This research looks at how memory and thinking skills change in middle-aged Spanish people who don't have the brain changes usually seen in Alzheimer's disease. Scientists checked their brain fluid to confirm this. They used special methods to track these changes over time and created new ways to compare their scores that are more sensitive than regular tests. The results suggest these new methods might be slightly better at finding very early, subtle declines in memory, which could be a sign of preclinical Alzheimer's. This study hopes to provide doctors with another tool to help spot early changes that might lead to Alzheimer's later in life.

Read More
AI, Clinical Trials, Technology, Health Equity Corey Hubbard AI, Clinical Trials, Technology, Health Equity Corey Hubbard

AI for Research Recruitment and Retention

Explore the critical topic of minority engagement in US clinical research on the Glassbury Cares Podcast. We discuss the persistent challenges of lower participation rates among racial and ethnic minorities in clinical trials, including HIV research. Understand how distrust of the medical community and research, significantly influenced by historical events like the Tuskegee study, acts as a barrier. Learn about other impediments, such as accessibility issues, time commitments, language barriers, stigma, and limited knowledge. Discover facilitators that encourage participation, including altruism, perceived personal and community benefits, trust, culturally relevant services, and monetary compensation. We examine ethical considerations, the importance of justice, and strategies like community-based participatory research to build trust and address structural barriers

Read More